Cargando…
Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
Facioscapulohumeral muscular dystrophy (FSHD) is a progressive myopathy with a relatively late age of onset (usually in the late teens) compared with Duchenne and many other muscular dystrophies. The current FSHD disease model postulates that contraction of the D4Z4 array at chromosome 4q35 leads to...
Autores principales: | Stadler, Guido, King, Oliver D, Robin, Jerome D, Shay, Jerry W, Wright, Woodring E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927483/ https://www.ncbi.nlm.nih.gov/pubmed/25003004 http://dx.doi.org/10.4161/rdis.26142 |
Ejemplares similares
-
Telomere Position Effect (TPE) Regulates DUX4 in Human
Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Stadler, Guido, et al.
Publicado: (2013) -
SORBS2 transcription is activated by telomere position effect–over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy
por: Robin, Jérôme D., et al.
Publicado: (2015) -
The immune system in Duchenne muscular dystrophy: Friend or foe
por: Villalta, S Armando, et al.
Publicado: (2015) -
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy
por: Whitehead, Nicholas P., et al.
Publicado: (2016) -
Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy
por: Pantoja, Mario, et al.
Publicado: (2013)